---
title: "CICC Remains a Buy on Pacific Basin Shipping (PCFBF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278824321.md"
description: "CICC has maintained a Buy rating on Pacific Basin Shipping (PCFBF) with a price target of HK$3.40, while the shares closed at HK$3.13. The analyst consensus suggests a Hold rating with an average price target of HK$3.52, indicating a 12.51% upside. J.P. Morgan also supports a Buy rating with a target of HK$4.10."
datetime: "2026-03-12T05:25:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278824321.md)
  - [en](https://longbridge.com/en/news/278824321.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278824321.md)
---

# CICC Remains a Buy on Pacific Basin Shipping (PCFBF)

CICC analyst maintained a Buy rating on Pacific Basin Shipping yesterday and set a price target of HK$3.40. The company’s shares closed last Monday at HK$3.13.

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

The word on The Street in general, suggests a Hold analyst consensus rating for Pacific Basin Shipping with a HK$3.52 average price target, a 12.51% upside from current levels. In a report released on March 4, J.P. Morgan also maintained a Buy rating on the stock with a HK$4.10 price target.

### Related Stocks

- [02343.HK](https://longbridge.com/en/quote/02343.HK.md)

## Related News & Research

- [Huatai Securities Reaffirms Their Buy Rating on Pacific Basin Shipping (PCFBF)](https://longbridge.com/en/news/278232766.md)
- [Bank of America Securities Keeps Their Buy Rating on Air China (AIRC)](https://longbridge.com/en/news/282300967.md)
- [Orient Overseas International Ltd. (OTCMKTS:OROVY) Short Interest Update](https://longbridge.com/en/news/282399708.md)
- [Over 20 commercial ships have transited through Strait of Hormuz in the last 24 hours, WSJ reports](https://longbridge.com/en/news/282739934.md)
- [Jefferies Remains a Buy on C4 Therapeutics (CCCC)](https://longbridge.com/en/news/282349247.md)